Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by University of Pennsylvania.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01300988
First received: December 16, 2010
Last updated: February 22, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)